The use of diabetes drugs in Canadian drug plans: H82-23/2016-PDF
Utilisation des médicaments contre le dibète dans les régimes publics d'assurance-médicaments du Canada.
"The cost of diabetes treatment has been rapidly increasing in Canada in recent years. While the growing prevalence of the disease is a contributing factor, more expensive treatments have been a major cost driver, especially given the uptake in new, higher-cost drugs. This study analyzes these issues from the perspective of Canadian public drug plans, and provides insight into the actual use of the newer and higher-cost diabetes drugs and their associated cost pressures. Results are presented for all public drug plans participating in NPDUIS: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and Health Canada’s Non-Insured Health Benefits drug plan. This analysis will support policy decision makers and the health technology assessment community in determining the future impact of diabetes treatments on their plans."
|Department/Agency||Patented Medicine Prices Review Board.|
|Title||The use of diabetes drugs in Canadian drug plans|
|Subtitle||Utilisation des médicaments contre le dibète dans les régimes publics d'assurance-médicaments du Canada.|
|Language||Bilingual-[English | French]|
|Electronic Document|| |
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.
We invite you to consult the Frequently Asked Questions page for additional information regarding the Archived Content notice.
Note: The URLs contained in this/these document(s) may no longer be functional
|Note||Caption title. At head of title: National Prescription Drug Utilization Information System.|
|Number of Pages|| p. :|
|Subject Terms||Diabetes, Drug insurance, Prescription drugs, Prices|
- Date modified: